Drugmaker Teva makes $40B bid for rival Mylan
Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst | Fierce Pharma
Mylan, Generic Copaxone Punish Teva (NYSE:TEVA) | Seeking Alpha
Teva prices EpiPen generic at $300, same price as Mylan generic
Teva shares rival Mylan's pain as both hit two-year lows | Fierce Pharma
FDA Approves Teva's Generic EpiPen As Stock Rises
Mylan/Viatris and Teva at the 38th Annual J.P. Morgan Healthcare Conference - MidgardFinance.com
Tamoxifen Detective: How I got my Teva back | The small c
Mylan rejects Teva takeover bid as too low | Mint
Mylan vs. Teva: Which Is the Better Generics Stock Ahead of Earnings?
Generic EpiPen by Teva Wins FDA Nod After 2 Year Delay | Fierce Pharma
Mylan surges, Teva slumps after FDA approves Copaxone copy | Reuters.com
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare IT News
Teva settles litigation with Mylan over Nuvigil - Pharmaceutical Technology
How Mylan tried to keep Teva from selling a generic EpiPen
Teva Pharmaceutical Gains Approval For Generic EpiPen, Mylan Shares Flat
Why Is This Generic Manufacturer Being Trampled by Its Industry Rivals? | The Motley Fool
Teva Offers to Buy Mylan for $40 Billion - WSJ
Mylan vs Teva Pharmaceuticals | Comparably
Therapeutically equivalent to EpiPen®
The Teva vs. Mylan drug war - The Jerusalem Post
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
